Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis
Alimentary Pharmacology & Therapeutics2018Vol. 49(2), pp. 140–146
Citations Over TimeTop 10% of 2018 papers
Tadayuki Oshima, Eitatsu Arai, Masato Taki, Takashi Kondo, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari, Hiroto Miwa
Abstract
Complete sustained heartburn relief was achieved sooner with vonoprazan than with lansoprazole during the first week of therapy. (UMIN000018776).
Related Papers
- → Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia(2013)13 cited
- → Heartburn severity can predict pathologic oesophageal reflux in gastro‐oesophageal reflux disease patients treated with a proton‐pump inhibitor(2003)6 cited
- → Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis(1998)3 cited
- → Proton Pump Inhibitor Clinical Trials: Focus On Lansoprazole In The Treatment Of Gastroesophageal Reflux Disease And Frequent Heartburn(2011)